Sign in
4

Changes in Ownership

Nuo Therapeutics, Inc. Filed Acc 0001437749-25-024497

CEO/CFO acquired 192,710 shares (option exercise)

  • CEO/CFO gave up 21,313 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

JORDEN DAVID EMERSON · CEO/CFO

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2025-08-01 Exercise or conversion : show line 1 in the form +100,000 $0.40 $40,000 2,075,358 D
2025-08-01 Exercise or conversion : show line 2 in the form +92,710 $0.40 $37,084 2,168,068 D
2025-08-01 Shares withheld for taxes : show line 3 in the form −21,313 $1.74 $37,085 2,146,755 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2018-08-09 Exercise or conversion : show line 4 in the form Option to purchase common stock −192,710 0 D
Loading xslF345X05/rdgdoc.xml…